Securing seed financing is just the first for MedTech startups on the journey to market access. This panel discussion gathering expert investors and successful entrepreneurs aims to provide a better understanding of the timelines, operations, and budgets required to best measure the available funding options at the onset of new start-ups. How do startups and investors navigate the transition from seed funding to scaling financing for market access? How do they collaborate to optimise financing strategies? What role do regulatory considerations and reimbursement pathways play in shaping financing decisions? What lessons can be learned from successful start-up scaling pathways?
Moderator: Arezki Yaïche, Head of Coverage France & Benelux, Mergermarket (ION Group) 
